FAAH2抗体

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P08301(FAAH2 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human brain  tissue using P08301(FAAH2 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The fatty acid amide hydrolase 2 (FAAH2) antibody is a research tool designed to detect and study FAAH2. a lesser-characterized enzyme within the FAAH family. FAAH2 shares partial homology with FAAH1. a well-known enzyme that hydrolyzes endocannabinoids like anandamide, regulating their signaling in pain, inflammation, and mood. However, FAAH2 exhibits distinct biochemical properties, including preferential activity in acidic environments and unique substrate specificity, suggesting divergent biological roles. It is expressed in tissues such as the testes, immune cells, and specific brain regions, though its physiological functions remain under investigation.

The FAAH2 antibody enables researchers to localize and quantify FAAH2 expression in cells and tissues via techniques like Western blotting, immunohistochemistry, or ELISA. It has become critical for exploring FAAH2's potential involvement in lipid metabolism, cellular stress responses, and interactions with the endocannabinoid system. Studies using this antibody aim to clarify whether FAAH2 complements or opposes FAAH1 activity, or if it processes distinct lipid substrates. Its development also supports drug discovery efforts targeting FAAH enzymes for conditions like neuropathic pain or metabolic disorders. Despite progress, FAAH2's precise role and therapeutic relevance require further elucidation, highlighting the antibody's importance in advancing this niche field.